---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-036853"
form_type: "8-K"
ticker: "RDGL"
cik: "0001449349"
company_name: "VIVOS INC"
filed_at: "2023-10-11T23:59:59+00:00"
generated_at: "2026-06-10T01:35:59.763292+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Vivos posts quarterly update: patent progress, Y-90 cost cut, new clinics

## Summary
- Filed utility patent for chiller; hydrogel patent nationalized in over 10 offices covering 63 countries.
- New Y-90 source from Eckert & Ziegler Wilmington MA reduces cost by ~$1,000 per therapy.
- Certified three new clinics: Indian Creek Veterinary Hospital (small animal) and two equine clinics.
- IDE amendment in preparation addressing 60 FDA comments; VX-2 rabbit study ongoing (12 of 21 treated).
- Mayo Clinic protocol submitted for IRB pre-review; full-dress rehearsal planned next quarter.

## SEC filing metadata
- accession: 0001493152-23-036853
- form_type: 8-K
- ticker: RDGL
- cik: 0001449349
- company_name: VIVOS INC
- filed_at: 2023-10-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1449349/000149315223036853/0001493152-23-036853-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1449349/000149315223036853/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-036853
- JSON: https://secwatch.observer/filing/0001493152-23-036853.json
- Plain text: https://secwatch.observer/filing/0001493152-23-036853.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.